MarketPulse
M

$MNOV

2 articles found
1 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Medicinova, Inc.

Study Validates MediciNova's Brain Metastasis Drug as Cancer Research Advances

MediciNova's drug candidate gains validation in peer-reviewed Cancer Research study, with CNIO identifying MIF signaling as brain metastasis target and potential CSF biomarker for patient stratification.
MNOVbiomarkerbrain metastasis
GlobeNewswire Inc.GlobeNewswire Inc.··Medicinova, Inc.

MediciNova to Present Pipeline Progress at 2026 ROTH Conference

MediciNova executives to present clinical pipeline at March 2026 ROTH Conference, conducting direct investor meetings in Dana Point.
MNOVclinical trialsbiopharmaceutical